Revisiting Congenital Atransferrinemia: A Rare but Treatable Cause of Pediatric Heart Failure

Congenital atransferrinemia is an extremely rare autosomal recessive disorder characterized by functional or quantitative deficiency of transferrin. This leads to a characteristic clinical picture that includes heart failure due to iron overload cardiomyopathy, severe anemia, as well as hepatic and endocrine dysfunction in early infancy. Although rare or may be underdiagnosed, congenital atransferrinemia is a treatable cause of infantile heart failure and iron overload cardiomyopathy. Therefore, it is important to keep this diagnosis as a possibility in childhood presentation of heart failure and anemia. Early diagnosis and timely treatment can prevent progressive myocardial dysfunction and recurrent heart failure. This article focuses on pathophysiology, diagnosis, genetics, and management of heart failure in congenital atransferrinemia.

Authors

Institutions

Publication Details

Journal
Cardiovascular & Haematological Disorders - Drug Targets
Published
2025-11-10
DOI
https://doi.org/10.2174/011871529x399774251016072809
Primary Topic
Iron Metabolism and Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Revisiting Congenital Atransferrinemia: A Rare but Treatable Cause of Pediatric Heart Failure

K Prakashini, Krishnananda Nayak, Tom Devasia, Monika Jawanjal et al.
Cardiovascular & Haematological Disorders - Drug Targets
Iron Metabolism and Disorders
article

Revisiting Congenital Atransferrinemia: A Rare but Treatable Cause of Pediatric Heart Failure

K Prakashini, Krishnananda Nayak, Tom Devasia, Monika Jawanjal, Shrikiran Hebbar
article en

Abstract

Congenital atransferrinemia is an extremely rare autosomal recessive disorder characterized by functional or quantitative deficiency of transferrin. This leads to a characteristic clinical picture that includes heart failure due to iron overload cardiomyopathy, severe anemia, as well as hepatic and endocrine dysfunction in early infancy. Although rare or may be underdiagnosed, congenital atransferrinemia is a treatable cause of infantile heart failure and iron overload cardiomyopathy. Therefore, it is important to keep this diagnosis as a possibility in childhood presentation of heart failure and anemia. Early diagnosis and timely treatment can prevent progressive myocardial dysfunction and recurrent heart failure. This article focuses on pathophysiology, diagnosis, genetics, and management of heart failure in congenital atransferrinemia.

Cardiovascular & Haematological Disorders - Drug TargetsVol. 26
Kasturba Medical College, Manipal (IN)
Openalex Percentile: Top 56%
Iron Metabolism and Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Revisiting Congenital Atransferrinemia: A Rare but Treatable Cause of Pediatric Heart Failure — K Prakashini, Krishnananda Nayak, et al. · Cardiovascular & Haematological Disorders - Drug Targets (2025) | TGRS Research Map | TGRS